With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer Directed Therapy||Dana-Farber Cancer Institute / Andrew Hong, MD||Young Investigator Grants||2015||Massachusetts|
|Zebrafish Modeling of PAX3-FOXO1 Driven Rhabdomyosarcoma||University of Texas Southwestern Medical Center / Genevieve Kendall, PhD||Young Investigator Grants||2015||Texas|
|Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene||Baylor College of Medicine / Robin Parihar, MD, PhD||Young Investigator Grants||2015||Texas|
|Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma||University of California San Francisco / Ozlem Aksoy, PhD||Young Investigator Grants||2015||California|
|Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia||University of California San Francisco / Elliot Stieglitz, MD||Young Investigator Grants||2015||California|
|Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma||University of California San Francisco / Zhenyi An, PhD||Young Investigator Grants||2015||California|
|CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma||Children's Hospital of Philadelphia / Robyn Sussman, PhD||Young Investigator Grants||2015||Pennsylvania|
|Elucidating the Mechanism of ERK Mediated Pathogenesis of LCH||Baylor College of Medicine / Rikhia Chakraborty, PhD||Young Investigator Grants||2015||Texas|
|The Cebpa Downstream Enhancer as a Key Target of Transformation to Acute Myeloid Leukemia||The Johns Hopkins University School of Medicine / Stacy Cooper, MD||Young Investigator Grants||2015||Maryland|
|The Role of DEF and SSU Processome in Neuroblastoma Pathogenesis||Dana-Farber Cancer Institute / Ting Tao, PhD||Young Investigator Grants||2015||Massachusetts|